Instruction of mesenchymal cell fate by the transcription factor C/EBPβ

Gene

Volumn 497, Issue 1, 2012, Pages 10-17

  Smink, Jeske J ^a,b   Leutz, Achim ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b Codon AG ^*  (Germany)

Author keywords

Adipocytes; C EBPbeta; Cell fate; Chondrocytes; Mesenchymal stem cells; Osteoblasts

Indexed keywords

ARGININE; CCAAT ENHANCER BINDING PROTEIN BETA; ISOPROTEIN; KRUPPEL LIKE FACTOR; LEUCINE ZIPPER PROTEIN; LYSINE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SERINE; SMAD3 PROTEIN; THREONINE; TYROSINE;

ACETYLATION; ADIPOCYTE; ADIPOGENESIS; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CHONDROGENESIS; CODON; ENZYME ACTIVITY; FIBROBLAST; GENE DUPLICATION; GENE OVEREXPRESSION; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; REGENERATIVE MEDICINE; REVIEW; RIBOSOME; SIGNAL TRANSDUCTION; SUMOYLATION; TISSUE ENGINEERING; TRANSCRIPTION REGULATION;

ADIPOCYTES; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CHONDROCYTES; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; PROTEIN ISOFORMS; TISSUE ENGINEERING;

EID: 84857800070     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.043     Document Type: Review

References (101)

1. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
2. Akune T., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 2004, 113:846-855.
3. Bae E.J., Kim S.G. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation. Mol. Pharmacol. 2005, 68:660-669.
4. Baek W.Y., Kim J.E. Transcriptional regulation of bone formation. Front. Biosci. (Schol Ed) 2011, 3:126-135.
5. Banerjee S.S., et al. The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis. J. Biol. Chem. 2003, 278:2581-2584.
6. Begay V., Smink J., Leutz A. Essential requirement of CCAAT/enhancer binding proteins in embryogenesis. Mol. Cell. Biol. 2004, 24:9744-9751.
7. Bell A., Grunder L., Sorisky A. Rapamycin inhibits human adipocyte differentiation in primary culture. Obes. Res. 2000, 8:249-254.
8. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 1992, 102(Pt 2):341-351.
9. Birsoy K., Chen Z., Friedman J. Transcriptional regulation of adipogenesis by KLF4. Cell Metab. 2008, 7:339-347.
10. Bostrom P., et al. C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010, 143:1072-1083.
11. Burk O., Mink S., Ringwald M., Klempnauer K.H. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J. 1993, 12:2027-2038.
12. Calkhoven C.F., Muller C., Leutz A. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev. 2000, 14:1920-1932.
13. Cao Z., Umek R.M., McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991, 5:1538-1552.
14. Carmona M.C., et al. Dual effects of sodium tungstate on adipocyte biology: inhibition of adipogenesis and stimulation of cellular oxygen consumption. Int. J. Obes. (Lond) 2009, 33:534-540.
15. Chan G.K., Duque G. Age-related bone loss: old bone, new facts. Gerontology 2002, 48:62-71.
16. Chen S.S., Chen J.F., Johnson P.F., Muppala V., Lee Y.H. C/EBPbeta, when expressed from the C/EBPalpha gene locus, can functionally replace C/EBPalpha in liver but not in adipose tissue. Mol. Cell. Biol. 2000, 20:7292-7299.
17. Chen Z., Torrens J.I., Anand A., Spiegelman B.M., Friedman J.M. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab. 2005, 1:93-106.
18. Cho H.J., Park J., Lee H.W., Lee Y.S., Kim J.B. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem. Biophys. Res. Commun. 2004, 321:942-948.
19. Choy L., Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 2003, 278:9609-9619.
20. Corradetti M.N., Guan K.L. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?. Oncogene 2006, 25:6347-6360.
21. Dingwall M., Marchildon F., Gunanayagam A., Louis C.S., Wiper-Bergeron N. Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells. Differentiation 2011, 82:57-65.
22. Dorheim M.A., et al. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J. Cell. Physiol. 1993, 154:317-328.
23. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 31:747-754.
24. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 2006, 4:263-273.
25. Grandy R., et al. The Ric-8B gene is highly expressed in proliferating pre-osteoblastic cells and down-regulated during osteoblast differentiation in a SWI/SNF- and C/EBP{beta}-mediated manner. Mol. Cell. Biol. 2011, 31:2997-3008.
26. Guo S., et al. Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta. J. Biol. Chem. 2001, 276:8516-8523.
27. Gutierrez S., et al. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 2002, 277:1316-1323.
28. Hamm J.K., Park B.H., Farmer S.R. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 2001, 276:18464-18471.
29. Harrison J.R., et al. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. J. Biol. Chem. 2005, 280.
30. Hata K., et al. A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol. Cell. Biol. 2005, 25:1971-1979.
31. Henriquez B., et al. C/EBPbeta binds the P1 promoter of the Runx2 gene and up-regulates Runx2 transcription in osteoblastic cells. J. Cell. Physiol. 2011, 226:3043-3052.
32. Hirata M., et al. C/EBPbeta promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS One 2009, 4:e4543.
33. Hirata M., et al. C/EBPbeta and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2alpha as the inducer in chondrocytes. Hum. Mol. Genet. 2011, doi:10.1093/hmg/ddr540 (Electronic publication ahead of print).
34. Iyer V.V., Kadakia T.B., McCabe L.R., Schwartz R.C. CCAAT/enhancer-binding protein-beta has a role in osteoblast proliferation and differentiation. Exp. Cell Res. 2004, 295:128-137.
35. Jimenez M.A., Akerblad P., Sigvardsson M., Rosen E.D. Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol. Cell. Biol. 2007, 27:743-757.
36. Jones L.C., et al. Expression of C/EBPbeta from the C/EBPalpha gene locus is sufficient for normal hematopoiesis in vivo. Blood 2002, 99:2032-2036.
37. Jundt F., et al. A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas. Blood 2005, 106:1801-1807.
38. Kajimura S., et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009, 460:1154-1158.
39. Karsenty G. Transcriptional control of skeletogenesis. Annu. Rev. Genomics Hum. Genet. 2008, 9:183-196.
40. Karsenty G., Kronenberg H.M., Settembre C. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 2009, 25:629-648.
41. Kim J.E., Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004, 53:2748-2756.
42. Kirkland J.L., Tchkonia T., Pirtskhalava T., Han J., Karagiannides I. Adipogenesis and aging: does aging make fat go MAD?. Exp. Gerontol. 2002, 37:757-767.
43. Kobayashi H., Gao Y., Ueta C., Yamaguchi A., Komori T. Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem. Biophys. Res. Commun. 2000, 273:630-636.
44. Koutnikova H., et al. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14457-14462.
45. Kowenz-Leutz E., Leutz A. A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell 1999, 4:735-743.
46. Lau W.F., Tertinegg I., Heersche J.N. Effects of retinoic acid on cartilage differentiation in a chondrogenic cell line. Teratology 1993, 47:555-563.
47. Lecka-Czernik B., Moerman E.J., Grant D.F., Lehmann J.M., Manolagas S.C., Jilka R.L. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002, 143:2376-2384.
48. Lee K.W., et al. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev. 2010, 19:557-568.
49. Lefterova M.I., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22:2941-2952.
50. Leutz A., Pless O., Lappe M., Dittmar G., Kowenz-Leutz E. Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs. Transcription 2011, 2:3-8.
51. Li D., et al. Kruppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J. Biol. Chem. 2005, 280:26941-26952.
52. Li Y., et al. Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. J. Biol. Chem. 2008, 283:22443-22456.
53. Linhart H.G., et al. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12532-12537.
54. Moerman E.J., Teng K., Lipschitz D.A., Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004, 3:379-389.
55. Mori T., et al. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 2005, 280:12867-12875.
56. Mori K., et al. Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk. Cancer Sci. 2008, 99:2170-2176.
57. Motyl K.J., Raetz M., Tekalur S.A., Schwartz R.C., McCabe L.R. CCAAT/enhancer binding protein beta-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R1250-R1260.
58. Muruganandan S., Roman A.A., Sinal C.J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell. Mol. Life Sci. 2009, 66:236-253.
59. Nakashima K., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
60. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007, 17:318-324.
61. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr. Opin. Cell Biol. 2008, 20:180-185.
62. Ness S.A., Kowenz-Leutz E., Casini T., Graf T., Leutz A. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev. 1993, 7:749-759.
63. Nishio Y., Isshiki H., Kishimoto T., Akira S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol. Cell. Biol. 1993, 13:1854-1862.
64. Novack D.V., Teitelbaum S.L. The osteoclast: friend or foe?. Annu. Rev. Pathol. 2008, 3:457-484.
65. Oishi Y., et al. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 2005, 1:27-39.
66. Okazaki K., Li J., Yu H., Fukui N., Sandell L.J. CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta. J. Biol. Chem. 2002, 277:31526-31533.
67. Phornphutkul C., Wu K.Y., Auyeung V., Chen Q., Gruppuso P.A. mTOR signaling contributes to chondrocyte differentiation. Dev. Dyn. 2008, 237:702-712.
68. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
69. Rokutanda S., et al. Akt regulates skeletal development through GSK3, mTOR, and FoxOs. Dev. Biol. 2009, 328:78-93.
70. Rosen E.D., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4:611-617.
71. Rosen E.D., et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002, 16:22-26.
72. Sanchez C.P., He Y.Z. Bone growth during rapamycin therapy in young rats. BMC Pediatr. 2009, 9:3.
73. Sebastian T., Johnson P.F. Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 2006, 5:953-957.
74. Siersbaek R., et al. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011, 30:1459-1472.
75. Singha U.K., et al. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J. Cell. Biochem. 2008, 103:434-446.
76. Smink J.J., Leutz A. Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases. J. Mol. Med. 2010, 88:227-233.
77. Smink J.J., Begay V., Schoenmaker T., Sterneck E., de Vries T.J., Leutz A. Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB. EMBO J. 2009, 28:1769-1781.
78. Staiger J., et al. C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth. Carcinogenesis 2009, 30:832-840.
79. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 1997, 16:7432-7443.
80. Tang Q.Q., Otto T.C., Lane M.D. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:850-855.
81. Tominaga H., et al. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol. Biol. Cell 2008, 19:5373-5386.
82. Tseng W.P., Yang S.N., Lai C.H., Tang C.H. Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts. J. Cell. Physiol. 2010, 223:810-818.
83. Villagra A., et al. Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J. Biol. Chem. 2006, 281:22695-22706.
84. Wang Y., Sul H.S. Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab. 2009, 9:287-302.
85. Wang W., et al. Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development 2009, 136:4143-4153.
86. Wethmar K., Smink J.J., Leutz A. Upstream open reading frames: molecular switches in (patho)physiology. Bioessays 2010, 32:885-893.
87. Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., Hache R.J. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 2003, 22:2135-2145.
88. Wiper-Bergeron N., Salem H.A., Tomlinson J.J., Wu D., Hache R.J. Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:2703-2708.
89. Wiper-Bergeron N., St-Louis C., Lee J.M. CCAAT/enhancer binding protein beta abrogates retinoic acid-induced osteoblast differentiation via repression of Runx2 transcription. Mol. Endocrinol. 2007, 21:2124-2135.
90. Wu J., Lingrel J.B. Kruppel-like factor 2, a novel immediate-early transcriptional factor, regulates IL-2 expression in T lymphocyte activation. J. Immunol. 2005, 175:3060-3066.
91. Wu Z., Xie Y., Bucher N.L., Farmer S.R. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev. 1995, 9:2350-2363.
92. Wu Z., et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 1999, 3:151-158.
93. Xiang X., Zhao J., Xu G., Li Y., Zhang W. mTOR and the differentiation of mesenchymal stem cells. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43:501-510.
94. Yeh W.C., Bierer B.E., McKnight S.L. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:11086-11090.
95. Yeh W.C., Cao Z., Classon M., McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995, 9:168-181.
96. Zahnow C.A. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev. Mol. Med. 2009, 11:e12.
97. Zaidi M. Skeletal remodeling in health and disease. Nat. Med. 2007, 13:791-801.
98. Zanotti S., Stadmeyer L., Smerdel-Ramoya A., Durant D., Canalis E. Misexpression of CCAAT/enhancer binding protein beta (C/EBPb) causes osteopenia. J. Endocrinol. 2009, 201:263-274.
99. Zhang H.H., et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 2009, 4:e6189.
100. Zhang G., Jin B., Li Y.P. C/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J. 2011, 30:4323-4335.
101. Zhou Q.G., Peng X., Hu L.L., Xie D., Zhou M., Hou F.F. Advanced oxidation protein products inhibit differentiation and activate inflammation in 3T3-L1 preadipocytes. J. Cell. Physiol. 2010, 225:42-51.